Emotional responses to motion sickness in autonomous driving

In future autonomous cars, users, free from the primary task of driving, will have time and space to engage in other activities while traveling, such as reading a book, working on a laptop or watching a movie. Although the option for these activities are one of the great advantages of autonomous cars, this will also likely increase motion sickness (MS) inside the car. MS affects numerous individuals, and it occurs when the information received through the eyes differs from what is perceived by the body and the inner ear. Plus, MS can have an impact on the emotional component of the individuals experiencing it, making the experience of traveling in autonomous cars uncomfortable and difficult. Emotional design studies focus on the emotional response of individuals to a product or service. These studies typically employ self-report scales as assessment tools, such as SAM (Self-Assessment Manikin) and PrEmo (Product Emotion Measurement instrument). We present the first study measuring emotional responses to MS using both SAM and PrEmo scales. In our study, we induced MS by asking participants to watch a highly dynamic video of a first-person car trip. We also asked subjects to answer to SAM and PrEmo before and after the visualization of the video. Our results showed a change in the answers in time, that is, before vs. after the experience of MS. MS significantly altered individuals' emotional responses, worsening their condition. These results support the need for studies that reduce MS to improve the experience and well-being of individuals in autonomous cars.Landscape, Heritage and Territory Laboratory (Lab2PT), Ref. UID/04509/2020, financed by national funds (PIDDAC) through the FCT/MCTES and the European Structural and Investment Funds in the FEDER component, through the Operational Competitiveness and Internationalization Programme (COMPETE 2020) [Project n° 039334; Funding Reference: POCI- 01-0247-FEDER-039334]

Acute Capsaicin Analog Supplementation Improves 400 M and 3000 M Running Time-Trial Performance

International Journal of Exercise Science 13(2): 755-765, 2020. Objectives: Performance in running-based sport depends on the ability to perform repetitive high intensity muscle contractions. Previous studies have shown that capsaicin analog (CAP) (i.e. Capsiate) supplementation may improve this performance. The purpose of this study was to investigate the acute effect of CAP supplementation on short (400 m) and middle distance (3000 m) running time-trial performance, maximum heart rate (HR), and rate of perceived exertion (RPE). Methods: Twelve physically active men completed four randomized, double-blind trials: CAP condition (12 mg) or a placebo condition. Forty-five minutes after supplementation, the participants performed a 400- or 3000-meter running time trial. Time (in seconds) was recorded. HR was analyzed at rest and immediately post-exercise, and RPE was collected immediately after exercise. Results: For both the 400 m time-trial (CAP = 66.4 + 4.2 sec vs Placebo = 67.1 + 4.8 sec, p = 0.046) and the 3000 m time-trial (CAP = 893.9 ± 46.8 sec vs Placebo = 915.2 ± 67.6 sec, p = 0.015), the time in seconds was significantly less in the CAP compared to placebo conditions. There were no statistically significant differences for HR and RPE in any condition. Conclusion: In summary, acute CAP supplementation improved 400 m and 3000 m running time-trial performance in a distance-dependent way but without modifying the HR and RPE

Coaxial fibres incorporated with phase change materials for thermoregulation applications

Nowadays, the growing concern about improving thermal comfort in different structures (textiles, buildings, and pavements, among others) has stimulated research into phase change materials (PCMs). The direct incorporation of PCMs into composite materials can cause mechanical impacts. Therefore, this study focuses on the design of phase change coaxial fibres (PCFs), using commercial cellulose acetate (CA) or recycled CA obtained from cotton fabrics (CAt) as the sheath and polyethylene glycol (PEG) 2000 as the core, via the wet spinning method; the fibres vary in molecular weight, concentration and ejection velocity. The fibres were assessed for their optical, chemical, thermal, and mechanical properties. The presence of PEG2000 is confirmed in the core of the fibres. Thermal analyses revealed a mass loss at high temperatures, attributable to the presence of PEG2000. Notably, the fibres with CA (Mn 30,000) showed superior thermal and mechanical performance. The melting point of PEG2000 incorporated into these PCFs coincided with the melting point of pure PEG2000 (about 55 °C), with a slight deviation, indicating that PCFs were obtained. Finally, the results point to the application of the fibres in civil engineering materials requiring a phase change between 50 and 60 °C, providing promising prospects for their use in applications requiring thermoregulatory properties.This research was funded by the Portuguese Foundation for Science and Technology (FCT) under the projects MicroCoolPav EXPL/EQUEQU/1110/2021 and NanoAir PTDC/FISMAC/6606/2020 (https://doi.org/10.54499/PTDC/FIS-MAC/6606/2020) and within the framework of Strategic Funding UIDB/04650/2020, UIDB/04029/2020 (https://doi.org/10.54499/UIDB/04029/2020) and UID/QUI/0686/2020. I.R.S. and H.P.F. would like to thank FCT for their funding contracts 2022.00763.CEECIND (https://doi.org/10.54499/2022.00763.CEECIND/CP1718/CT0006) and 2021.02720.CEECIND (https://doi.org/10.54499/DL57/2016/CP1377/CT0098)

SARS‐CoV2 pneumonia recovery is linked to expansion of innate lymphoid cells type 2 expressing CCR10

© 2021 The Authors. European Journal of Immunology published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.Accelerate lung repair in SARS-CoV-2 pneumonia is essential for pandemic handling. Innate lymphoid cells (ILCs) are likely players, given their role in mucosal protection and tissue homeostasis. We studied ILC subpopulations at two time points in a cohort of patients admitted in the hospital due to SARS-CoV-2 infection. COVID-19 patients with moderate/severe respiratory failure featured profound depletion of circulating ILCs at hospital admission, in agreement with overall lymphocyte depletion. However, ILCs recovered in direct correlation with lung function improvement as measured by oxygenation index and in negative association with inflammatory and lung/endothelial damage markers like RAGE. While both ILC1 and ILC2 expanded, ILC2 showed the most striking phenotype changes, with CCR10 upregulation in strong correlation with these parameters. Overall, CCR10+ ILC2 emerge as relevant contributors to SARS-CoV-2 pneumonia recovery.This work was funded by the following grants from Fundação para a Ciência e a Tecnologia (FCT), Portugal, through “APOIO ESPECIAL RESEARCH4COVID-19,” project numbers 125 to SMF and 803 to ACT. AMCG and GBF received fellowships funded by FCT (DOCTORATES4COVID-19, 2020.10202.BD) and JANSSEN- CILAG FARMACÊUTICA, respectively.info:eu-repo/semantics/publishedVersio

The internal alignment and position resolution of the AMS-02 silicon tracker determined with cosmic-ray muons

Abstract The Alpha Magnetic Spectrometer is a large acceptance cosmic-ray detector ( 0.5 m 2 sr ) designed to operate at an altitude of 400 km on the International Space Station. The AMS-02 silicon tracker contains 2264 silicon microstrip sensors (total active area 6.75 m 2 ). The internal alignment parameters of the assembled tracker have been determined on the ground with cosmic-ray muons. The alignment procedure is described and results for the alignment precision and position resolution are reported

Use of metabolomics for the identification and validation of clinical biomarkers for preterm birth:Preterm SAMBA

Made available in DSpace on 2018-12-11T17:29:12Z (GMT). No. of bitstreams: 0 Previous issue date: 2016-08-08Background: Spontaneous preterm birth is a complex syndrome with multiple pathways interactions determining its occurrence, including genetic, immunological, physiologic, biochemical and environmental factors. Despite great worldwide efforts in preterm birth prevention, there are no recent effective therapeutic strategies able to decrease spontaneous preterm birth rates or their consequent neonatal morbidity/mortality. The Preterm SAMBA study will associate metabolomics technologies to identify clinical and metabolite predictors for preterm birth. These innovative and unbiased techniques might be a strategic key to advance spontaneous preterm birth prediction. Methods/design: Preterm SAMBA study consists of a discovery phase to identify biophysical and untargeted metabolomics from blood and hair samples associated with preterm birth, plus a validation phase to evaluate the performance of the predictive modelling. The first phase, a case-control study, will randomly select 100 women who had a spontaneous preterm birth (before 37 weeks) and 100 women who had term birth in the Cork Ireland and Auckland New Zealand cohorts within the SCOPE study, an international consortium aimed to identify potential metabolomic predictors using biophysical data and blood samples collected at 20 weeks of gestation. The validation phase will recruit 1150 Brazilian pregnant women from five participant centres and will collect blood and hair samples at 20 weeks of gestation to evaluate the performance of the algorithm model (sensitivity, specificity, predictive values and likelihood ratios) in predicting spontaneous preterm birth (before 34 weeks, with a secondary analysis of delivery before 37 weeks). Discussion: The Preterm SAMBA study intends to step forward on preterm birth prediction using metabolomics techniques, and accurate protocols for sample collection among multi-ethnic populations. The use of metabolomics in medical science research is innovative and promises to provide solutions for disorders with multiple complex underlying determinants such as spontaneous preterm birth.University of Campinas (UNICAMP) School of Medical Sciences Department of Obstetrics and Gynecology, R. Alexander Fleming, 101University of Auckland Gravida: National Centre for Growth and Development Liggins InstituteUniversity College Cork Irish Centre for Fetal and Neonatal Translational Research (INFANT) Department of Obstetrics and GynaecologyUniversity of Auckland South Auckland Clinical School Faculty of Medical and Health SciencesUniversity of Auckland School of Biological SciencesUniversity of Campinas (UNICAMP) LNBio-Brazilian Biosciences National Laboratory and School of Medical SciencesSchool of Medical Sciences University of CampinasLNBioSchool of Medicine of Botucatu UNESPSchool of Medicine Federal University of Rio Grande do SulSchool of Medicine Federal University of PernambucoSchool of Medicine Federal University of CearáKing's College London and King's Health PartnersMaternal and Fetal Health Research Centre University of ManchesterUniversity of LeedsUniversity of AdelaideSchool of Medicine of Botucatu UNES